Pfizer Says Ex-Execs Swiped Data For Rival Drug Startups
Pfizer has accused two former executives of stealing diabetes and cancer medication research for two biotechnology startups that they developed prior to their departure, according to a trade secrets suit filed...To view the full article, register now.
Already a subscriber? Click here to view full article